Literature DB >> 32625420

Update of the list of QPS-recommended biological agents intentionally added to food or feed as notified to EFSA 5: suitability of taxonomic units notified to EFSA until September 2016.

Antonia Ricci, Ana Allende, Declan Bolton, Marianne Chemaly, Robert Davies, Rosina Girones, Kostas Koutsoumanis, Lieve Herman, Roland Lindqvist, Birgit Nørrung, Lucy Robertson, Giuseppe Ru, Moez Sanaa, Marion Simmons, Panagiotis Skandamis, Emma Snary, Niko Speybroeck, Benno Ter Kuile, John Threlfall, Helene Wahlström, Pier Sandro Cocconcelli, Günter Klein Deceased, Luisa Peixe, Miguel Prieto Maradona, Amparo Querol, Juan Evaristo Suarez, Ingvar Sundh, Just Vlak, Sandra Correia, Pablo Salvador Fernández Escámez.   

Abstract

EFSA was requested to assess the safety of a broad range of biological agents in the context of notifications for market authorisation as sources of food and feed additives, enzymes and plant protection products. The qualified presumption of safety (QPS) assessment was developed to provide a harmonised generic pre-assessment to support safety risk assessments performed by EFSA's Scientific Panels. The safety of unambiguously defined biological agents (at the highest taxonomic unit appropriate for the purpose for which an application is intended) and the completeness of the body of knowledge were assessed. Safety concerns identified for a taxonomic unit are, where possible and reasonable in number, reflected as 'qualifications' in connection with a recommendation for a QPS status. A total of 57 biological agents were notified to EFSA between the end of April 2016 and the beginning of September 2016. From these, 34 biological agents already had a QPS status and did not require further evaluation, and 10 were not included in the evaluation as they are filamentous fungi or enterococci, biological groups which have been excluded from QPS evaluation since 2014. Three notifications for Streptomyces violaceoruber, one for Streptomyces albus, one for Bacillus circulans and four for Escherichia coli were not evaluated for QPS status because these species were recently assessed and considered not suitable for QPS status. Therefore, only four notifications related to three taxonomic units were evaluated for QPS status. Of these, Arthrobacter ramosus and Pseudomonas fluorescens are not recommended for the QPS list. Bacillus smithii is recommended for the QPS status.
© 2017 European Food Safety Authority. EFSA Journal published by John Wiley and Sons Ltd on behalf of European Food Safety Authority.

Entities:  

Keywords:  Arthrobacter ramosus; Bacillus smithii; Pseudomonas fluorescens; QPS; bacteria; safety; yeast

Year:  2017        PMID: 32625420      PMCID: PMC7328882          DOI: 10.2903/j.efsa.2017.4663

Source DB:  PubMed          Journal:  EFSA J        ISSN: 1831-4732


Summary

The European Food Safety Authority (EFSA) asked the Panel on Biological Hazards (BIOHAZ) to deliver a scientific Opinion on the maintenance of the list of QPS biological agents intentionally added to food or feed. The request included three specific tasks as mentioned in the Terms of Reference (ToR). In 2014, the BIOHAZ Panel decided to change the evaluation procedure: instead of publishing the overall assessment of the taxonomic units previously recommended for the QPS list annually, as prior to 2013, it is now carried out every 3 years in a scientific Opinion of the BIOHAZ Panel (the first adopted in December 2016). Meanwhile, the list of microorganisms is maintained and around every 6 months checked based on the evaluation of standardised extensive literature searches, a database that will be updated regularly with new publications. Intermediate deliverables in the form of a Panel Statement are produced and published when an assessment for a QPS classification of a microbiological agent notified to EFSA is requested by the Feed Unit, the Food Ingredients and Packaging (FIP) Unit, the Nutrition Unit or the Pesticides Unit. Evaluations of these notifications are compiled in a single Statement encompassing periods of around 6 months. The main results of these assessments since 2014 are included in the scientific Opinion of the BIOHAZ Panel to be published in January 2017. The ‘2013 updated list of QPS status recommended biological agents for safety risk assessments carried out by EFSA scientific Panels and Units’ has been updated with the inclusion of new recommendations for QPS status and is appended to each Panel Statement published until 2016. The current valid version of the QPS list is the one from the scientific Opinion published in January of 2017, also appended to the current Panel Statement. The first ToR requires ongoing updates of the list of biological agents being notified, in the context of a technical dossier to EFSA Units (such as Feed Unit, FIP Unit, Nutrition Unit, and Pesticides Unit), for intentional use in food and/or feed or as sources of food and feed additives, enzymes and plant protection products. The list was updated with the notifications received since the latest review and the new ones were included in a table appended to the current Statement (Appendix C). Notifications considered for the current Statement were received between the end of April 2016 and the beginning of September 2016. Within this period, 57 notifications were received from the four EFSA Units, of which 24 were from the Feed Unit, 28 from FIP, four from Nutrition, and one from the Pesticides Unit. The overall updated list of notifications received from the beginning of the QPS exercise in 2007 is appended to the scientific Opinion published in January of 2017. The second ToR concerns the revision of the taxonomic units previously recommended for the QPS list and their qualifications (especially the qualification regarding antimicrobial resistance) when new information became available and to update the information provided in the previous Opinion published in November 2013, where appropriate. The work being developed in order to meet this ToR is not reflected in the current Statement, but will be published in a scientific Opinion of the BIOHAZ Panel, in January of 2017. The third ToR requires a (re)assessment of the suitability of taxonomic units notified to EFSA not present in the current QPS list for their inclusion in the updated list. The current Statement focuses on this ToR by including the individual assessments of the taxonomic units not previously included in the 2013 QPS list and that were notified to EFSA between the end of April 2016 and the beginning of September 2016. Of the 57 notifications received, 34 biological agents already had QPS status and did not require further evaluation in this Statement. From the remaining 23 (without a QPS status), 10 were not further assessed as they are filamentous fungi or enterococci, biological groups that have been excluded from QPS since 2014. Three notifications for Streptomyces violaceoruber, one for Streptomyces albus and one for Bacillus circulans were not included because the pertinent taxonomic units have already been evaluated in the previous Statements of December of 2014 and of June of 2015 and found unsuitable for QPS. Four notifications of strains belonging to the species Escherichia coli were not included because the species had also been re‐evaluated in the previous Statement (2015) and was considered not suitable for QPS status. There were three notifications, notified by the FIP Unit, related to two taxonomic units and one for Feed Unit that were evaluated for QPS status. Arthrobacter ramosus and Pseudomonas fluorescens are not recommended for the QPS list. Bacillus smithii is recommended for the QPS list.

Introduction

In the context of applications for market authorisation of these biological agents, the European Food Safety Authority (EFSA) is requested by the EC, National competent Authorities or Applicants to assess the safety of microorganisms intentionally added at different stages into the food chain, either directly or as a source of food and feed additives, enzymes or plant protection products. The qualified presumption of safety (QPS) approach was developed by the EFSA Scientific Committee to provide a generic concept to prioritise and to harmonise risk assessment within EFSA of microorganisms intentionally introduced into the food chain, in support of the respective Scientific Panels and Units in the frame of authorisations (EFSA, 2007). The list, first established in 2007, has been revised and updated. Taxonomic units were included in the QPS list either following notifications to EFSA or following proposals made by stakeholders during a public consultation in 2005, even if they were not yet notified to EFSA (EFSA, 2005). For the update to be started in 2014, it was decided by the Scientific Committee and BIOHAZ Panel to change the procedures. The publication of the overall assessment of the taxonomic units previously recommended for the QPS list (EFSA BIOHAZ Panel, 2013) is now carried out every 3 years through a scientific Opinion by the Panel on Biological Hazards (BIOHAZ). In any case, the recommendations provided concerning that list of microorganisms will be maintained and every 6 months checked based on the evaluation of extensive literature reviews which will be updated regularly with new publications. Intermediate deliverables in the form of a Panel Statement are produced and published whenever an assessment for a QPS classification of a microbiological agent notified to EFSA is requested by Feed, Food Ingredients and Packaging (FIP), Nutrition, or Pesticides Units. Evaluations of these notifications are compiled in single Statements for periods of around 6 months. The results of these assessments are also included in the scientific Opinion published in January of 2017. The ‘2013 updated list of QPS status recommended biological agents for safety risk assessments carried out by EFSA Scientific Panels and Units’ to which new recommendations of taxonomic units for the QPS was included, was also appended to each Panel Statement published until 2016. QPS entered the European Union (EU) law with the publication of a new Commission Implementing Regulation (EU) No 562/20121 amending Commission Regulation (EU) No 234/20112 with regard to specific data required for risk assessment of food enzymes. If the microorganism used in the production of a food enzyme has a status of QPS according to the most recent list of QPS‐recommended biological agents adopted by the EFSA, the enzyme application would not be required to include toxicological data. If residues, impurities and degradation products linked to the total enzyme production process (production, recovery and purification) could give rise for concern, the Authority, pursuant to Article 6(1) of Regulation (EC) No 1331/20083, may request additional data for risk assessment, including toxicological data.

Background and Terms of Reference as provided by EFSA

Background as provided by EFSA

A wide variety of microorganisms are intentionally added at different stages into the food chain, either directly or as a source of additives or food enzymes or plant protection products. EFSA is requested to assess the safety of these biological agents in the context of applications received by EFSA for market authorisation as sources of food and feed additives, enzymes and plant protection products. The Scientific Committee of EFSA reviewed the range and numbers of microorganisms likely to be the subject of an EFSA Opinion and in 2007 published a list of microorganisms recommended for QPS,4 , 5 consisting of 48 species of Gram‐positive non‐sporulating bacteria, 13 Bacillus species and 11 yeast species. Filamentous fungi were also assessed but none was recommended for QPS status. The Scientific Committee recommended that a QPS approach should be implemented across EFSA and applied equally to all safety considerations of microorganisms that EFSA is required to assess. The Scientific Committee recognised that there would have to be continuous provision for reviewing and modifying the QPS list. The EFSA Panel on Biological Hazards (BIOHAZ) took the prime responsibility for this and annually reviewed the existing QPS list, as recommended by the Scientific Committee. In the first annual QPS review and update,6 the existing QPS list was reviewed and EFSA's initial experience in applying the QPS approach was described. The potential application of the QPS approach to microbial plant protection products was discussed in the 2009 review.7 In 2009, viruses and bacteriophages were assessed for the first time, leading to the addition of two virus families used for plant protection purposes to the QPS list. Bacteriophages were not considered appropriate for the QPS list. After consecutive years of updating the existing scientific knowledge, the filamentous fungi (2008–2013 updates) and enterococci (2010–2013 updates) were not recommended for the QPS list. The 2013 update of the recommended QPS list includes 53 species of Gram‐positive non‐sporulating bacteria, 13 Gram‐positive spore‐forming bacteria (Bacillus species), one Gram‐negative bacterium (Gluconobacter oxydans), 13 yeast species, and three virus families. No QPS‐recommended taxa have been taken down from the list following six (2008–2013 updates) annual reviews. Based on the above information, the BIOHAZ Panel at their plenary meeting in January 2014 made a proposal for future QPS activities that was discussed at the Scientific Committee meeting in March 2014. The Scientific Committee agreed to exclude some biological groups (filamentous fungi, bacteriophages and enterococci) in future QPS activities, while an extensive literature review of the QPS recommended list could be done less frequently. The deadline for the assessment of the suitability of new taxonomic units notified to EFSA for inclusion in the QPS list would be tailored to the needs of the requesting EFSA Units and/or Scientific Panels.

Terms of Reference as provided by EFSA

ToR 1: Keep updated the list of biological agents being notified, in the context of a technical dossier to EFSA Units (such as Feed, Pesticides, Food Ingredients and Packaging, and Nutrition), for intentional use in food and/or feed or as sources of food and feed additives, enzymes and plant protection products. ToR 2: Review taxonomic units previously recommended for the QPS list and their qualifications (especially the qualification regarding antimicrobial resistance) when new information has become available. Update the information provided in the previous opinion where appropriate. ToR 3: (Re)assess the suitability of taxonomic units notified to EFSA not present in the current QPS list for their inclusion in that list.

Data and methodologies

Data

For the taxonomic units associated with the notifications compiled within the time period covered by this Statement (from the end of April 2016 until the beginning of September 2016), the literature review considered the identity, the body of knowledge, history of use, and the potential safety concerns. Relevant databases such as PubMed, Web of Science, CasesDatabase, CAB Abstracts or Food Science Technology Abstracts (FSTA) and Scopus were searched. More details on the search strategy, search keys and approach followed are described in Appendix A. In February 2016, it was agreed to improve the assessment of the QPS status and its applicability for the Pesticides Unit by taking into account the data provided to EFSA within the applicant's dossier (that is required to include an extensive systematic literature review of the peer‐reviewed scientific literature).

Methodologies

In response to ToR1, the EFSA Units have been asked to update the list of biological agents being notified to EFSA. Fifty‐seven notifications were received between the end of April 2016 and the beginning of September 2016 of which 24 from the Feed Unit, 28 from FIP, four from the Nutrition Unit, and one from the Pesticides Unit (Table 1).
Table 1

Notifications received by EFSA Units (Feed, FIP, Nutrition, and Pesticides) by biological group from April 2016 until September 2016

Unit/PanelNot QPSAlready QPSGrand Total
Biological groupNot evaluatedEvaluated
Excluded in QPS 2013a Previously evaluatedb Evaluation in stand by
Feed/FEEDAP 3 4 1 16 24
Bacteria241916
Filamentous fungi11
Yeasts77
Nutrition/NDA 4 4
Bacteria44
Pesticides 1 1
Bacteria11
Filamentous fungi
Viruses
Yeasts
FIP/CEF 7 5 3 13 28
Bacteria531220
Filamentous fungi77
Yeasts11
Total 10 9 0 4 34 57

CEF: EFSA Panel on Food Contact Materials, Enzymes, Flavourings and Processing Aids; FEEDAP: EFSA Panel on Additives and products or Substances used in Animal Feed; FIP: EFSA Food ingredients and packaging Unit; NDA: EFSA Panel on Dietetic Products, Nutrition and Allergy; QPS: Qualified Presumption of Safety.

The number includes biological agents that belong to filamentous fungi and enterococci (excluded from QPS evaluation in the 2013 QPS Opinion).

The number includes biological agents that have been recently evaluated. Three notifications for Streptomyces violaceoruber and one for Streptomyces albus were not included because they have already been evaluated in the previous Statement of December of 2014 and found unsuitable for QPS (EFSA BIOHAZ Panel, 2014). Four notifications corresponding to four strains of E. coli were not included as the species has been previously evaluated and found unsuitable for QPS (EFSA BIOHAZ Panel, 2014). One notification corresponding to Bacillus circulans was not included because it was already evaluated in June 2015.

In response to ToR3, from those 57 notifications, 34 biological agents already had a QPS status and did not require further evaluation; neither did the 10 biological agents that are filamentous fungi or enterococci, which have been excluded from QPS activities (in the follow‐up of a recommendation of the QPS 2013 update (EFSA BIOHAZ Panel, 2013, 2014). Three notifications for Streptomyces violaceoruber, one for Streptomyces albus, and one for Bacillus circulans were not included because the corresponding taxonomic units have already been evaluated in the previous Statement of December of 2014 and June of 2015, respectively, and found unsuitable for QPS (EFSA BIOHAZ Panel, 2014, 2015a). Four notifications of strains belonging to Escherichia coli were not included as this species has been previously re‐evaluated and found unsuitable for QPS (EFSA BIOHAZ Panel, 2014). Three biological agents were assessed for their suitability for inclusion in the QPS list as the species were not previously assessed. They were notified to the EFSA Food Ingredients and packaging (FIP) (Arthrobacter ramosus and Pseudomonas fluorescens) and one to the Feed Unit (Bacillus smithii). The procedure followed for this assessment is the same as in the previous QPS 2013 update of the scientific Opinion (EFSA BIOHAZ Panel, 2013) and in the Panel Statements published in December 2014 and June and December 2015 and June 2016 (EFSA BIOHAZ Panel, 2014, 2015a,b, 2016). Notifications received by EFSA Units (Feed, FIP, Nutrition, and Pesticides) by biological group from April 2016 until September 2016 CEF: EFSA Panel on Food Contact Materials, Enzymes, Flavourings and Processing Aids; FEEDAP: EFSA Panel on Additives and products or Substances used in Animal Feed; FIP: EFSA Food ingredients and packaging Unit; NDA: EFSA Panel on Dietetic Products, Nutrition and Allergy; QPS: Qualified Presumption of Safety. The number includes biological agents that belong to filamentous fungi and enterococci (excluded from QPS evaluation in the 2013 QPS Opinion). The number includes biological agents that have been recently evaluated. Three notifications for Streptomyces violaceoruber and one for Streptomyces albus were not included because they have already been evaluated in the previous Statement of December of 2014 and found unsuitable for QPS (EFSA BIOHAZ Panel, 2014). Four notifications corresponding to four strains of E. coli were not included as the species has been previously evaluated and found unsuitable for QPS (EFSA BIOHAZ Panel, 2014). One notification corresponding to Bacillus circulans was not included because it was already evaluated in June 2015.

Bacteria

Arthrobacter ramosus

Identity

Arthrobacter ramosus is a Gram‐positive, aerobic and rod‐shaped species belonging to Micrococcaceae, firstly described by Jensen (1960). This species has the highest 16S rRNA gene sequence similarity with A. gyeryongensis (98.2% between both type strains), being, namely, differentiated by metabolic reactions.

Body of knowledge

A. ramosus produces trehalose from maltooligosaccharide and it can also produce an extracellular protease (Yamamoto et al., 2001). There is a very limited body of knowledge, with a total of 15 scientific papers retrieved and screened. Soil is considered the main habitat for arthrobacters in general (Crocker et al., 2000), although strains have been isolated from clinical specimens and may have been previously identified as CDC coryneform group B‐1 and B‐3 (Funke et al., 1996). Thus, several other Arthrobacter species have now been reported to be associated with human diseases such as peritonitis, erythema or endocarditis (A. sanguinis (Yap et al., 2015), A. mysorens (Imirzalioglu et al., 2010), A. woluwensis (Bernasconi et al., 2004)) and even some unnamed species (Busse et al., 2012). Although Arthrobacter spp. are widely present in nature and it is expected that A. ramosus is also present in soil and, therefore, in the food chain, there are no reports indicating the isolation of A. ramosus in food as contaminant, and there is no indication of the intentional use of the microorganism in foods or food ingredients to date.

Safety concerns

No information indicating any safety concern related to this specific taxonomic unit was found.

Antimicrobial resistance

No information about antimicrobial resistance aspects was found.

Conclusions on a recommendation for the QPS list

Due to a very limited body of knowledge and the association of some Arthrobacter spp. with human disease (although not food‐borne), QPS status cannot be granted to A. ramosus.

Bacillus smithii

B. smithii is a rod‐shaped, motile, spore‐forming, facultatively anaerobic and facultatively thermophilic bacterium. This species is most closely related to B. coagulans, which is also a facultatively thermophilic species. The complete genome of B. smithii type strain (B. smithii DSM 4216T) is available (Bosma et al., 2016). There is a limited body of knowledge (48 references were found). As most spore‐forming bacteria, it is ubiquitous in nature, and therefore it is also present in many raw materials and dry ingredients of processed food such as milk products (Lücking et al., 2013). It also has potential for the production of enzymes and other compounds, e.g. nitrile hydratases (Takashima et al., 2000) and a thermophilic inulinase (Gao et al., 2009). B. smithii possesses a possible protective effect against Salmonella and Clostridium difficile (Suitso et al., 2007; Jögi et al., 2008). It has been considered a relevant microorganism for biotechnological purposes, namely for conversion of biomass to fuel or chemicals, (Bosma et al., 2015). Cytotoxicity assays using Vero and HEp‐2 cells in several Bacillus spp. strains, including B. smithii, did not identify any cytotoxic components, indicating that the risk of food‐borne disease is most likely low if at all (Lücking et al., 2013). Since members of this species were in the past probably assigned to B. coagulans, a species with QPS status, additional safety concerns related to misidentification are not expected. No information related to the presence of antimicrobial resistance determinants in members of this taxon has been identified. The species B. smithii is a natural component of bacterial communities of fermented vegetables and plant‐derived products. Considering the lack of evidence of pathogenicity, it can be recommended for the QPS list with a qualification of absence of toxigenic activity (as applied to all strains of Bacillus species recommended to the QPS list).

Pseudomonas fluorescens

Pseudomonas fluorescens is a Gram‐negative rod, motile, unable to ferment glucose, and oxidase and pyoverdin producer. The taxonomy of Pseudomonas genus has evolved, with the multi locus sequence analysis (MLSA) of four housekeeping genes (16S rRNA, gyrB, rpoB and rpoD genes) (Mulet et al., 2012). In fact, MLSA has demonstrated that a significant number of Pseudomonas strains are not correctly assigned at the species level, with errors also including P. fluorescens strain assignments (Mulet et al., 2012). Several complete genomes of P. fluorescens strains are available (Gomila et al., 2015). P. fluorescens is a ubiquitous bacterium commonly encountered in aquatic, aerial and soil matrices, and more specifically in spoiled food, rhizospheres and surfaces of plants, as well as a coloniser of mammalian hosts (Bergsma‐Vlami et al., 2005; Dickson et al., 2014). This metabolically versatile species produces a large number of secondary metabolites enabling it to succeed in competing with other microorganisms, and also making it of interest for biotechnology applications. Examples include hydrogen cyanide, suppressing plant disease, which may be produced in rhizosphere‐inhabiting P. fluorescens, and phenazine compounds with antitumour, antiparasitic and antimicrobial activities (Ramette et al., 2003; Mavrodi et al., 2006). Of note is the production of pyrrolnitrin, an antifungal compound formulated for clinical and agricultural use, and the production of pseudomonic acids, with mupirocin used for prevention of methicillin‐resistant Staphylococcus aureus infections (Sutherland et al., 1985; Villiger et al., 1986; Umio et al., 1987; Ligon et al., 2000). P. fluorescens has been considered to be an opportunistic pathogen, involved in acute nosocomial infections, and with a rapid increase in cases over the last few years (CDC, 2005, 2006). Production of bioactive secondary metabolites, haemolysins, siderophores, type III secretion system, the ability to form biofilms and to adapt to growth at higher temperatures are functional features that have been associated with the ability to cause disease in humans (Scales et al., 2014; Mazurier et al., 2015). A new possible clinically important issue of this bacterium is the “association” between P. fluorescens and Crohn's disease in humans, as revealed by the detection of a highly specific antigen of P. fluorescens (designated as I2) in the serum of 54% of Crohn's patients (Sutton et al., 2000; Dalwadi et al., 2001). Moreover, the possibility that P. fluorescens may be as common as Helicobacter pylori in the human gastrointestinal tract was recently described (Patel et al., 2013). Intrinsic antimicrobial resistance mechanisms, namely efflux pumps belonging to the resistance‐nodulation‐division (RND) superfamily, have been described in P. fluorescens (Adebusuyi and Foght, 2011). Moreover, different acquired resistance genes have also been associated with this opportunistic bacterial species (e.g. blaVIM‐2, blaIMP‐1, and blaIMP‐22 conferring resistance to carbapenems) (Koh et al., 2004; Pellegrini et al., 2009; Abigail et al., 2011; Rubin et al., 2014). The pathogenic potential of P. fluorescens demonstrated by its implication in human infections and virulence features is an important safety concern, preventing its recommendation for the QPS list. Moreover, the possibility of mupirocin‐resistant S. aureus strains selection, as a result of P. fluorescens ability to produce mupirocin, further supports the rejection of the QPS status.

Conclusions

ToR 1: Keep updated the list of biological agents being notified, in the context of a technical dossier to EFSA Units (such as Feed, Food Ingredients and Packaging (FIP), Nutrition Unit and Pesticides Unit), for intentional use in feed and/or food or as sources of food and feed additives, enzymes and plant protection products for safety assessment: Between the end of April 2016 and the beginning of September 2016, 57 notifications were received from those four Units, of which 24 were from the Feed Unit, 28 from FIP, four from Nutrition, and one from the Pesticides Unit. ToR 2: Review taxonomic units previously recommended for the QPS list and their qualifications (especially the qualification regarding antimicrobial resistance) when new information has become available: The work being developed in order to reply to this ToR is not reflected in the current Panel Statement. This ToR is being dealt with by the QPS working group and the ongoing revision of the overall assessment of the biological agents included in the 2013 QPS update Opinion will be published through a scientific Opinion of the BIOHAZ Panel in January of 2017. ToR 3: (Re)assess the suitability of taxonomic units notified to EFSA not present in the current QPS list for their inclusion in that list: Of the 57 notifications received, 34 biological agents already had a QPS status and did not require further evaluation. From the remaining 23 notifications (without a QPS status), 10 were not further assessed as they are filamentous fungi or enterococci, biological groups which have been excluded from QPS activities since 2014. Four notifications of strains belonging to E. coli were also not evaluated because the species has not been recommended for the QPS approach in the previous Statement of December of 2014 Three notifications for Streptomyces violaceoruber and one for Streptomyces albus, were not included because several species of the genus had already been evaluated in the previous Statement of December of 2014 and found unsuitable for QPS. One notification corresponding to Bacillus circulans was not included because it had already been evaluated in the Statement of June 2015 and found unsuitable for QPS. Four notifications were considered for the assessment of the suitability of the respective taxonomic units for inclusion in the QPS list. From the three taxonomic units assessed, two were notified by the FIP Unit (Arthrobacter ramosus and Pseudomonas fluorescens) and one to the Feed Unit (Bacillus smithii).

Recommendations

Arthrobacter ramosus and Pseudomonas fluorescens are not recommended for the QPS list. Bacillus smithii is recommended for the QPS status.

Abbreviations and Glossary

antibiotics, bacteriocins and/or small peptides EFSA Panel on Biological Hazards EFSA Panel on Food Contact Materials, Enzymes, Flavourings and Processing Aids EFSA Panel on Additives and Products or Substances used in Animal Feed EFSA Food ingredients and packaging Unit Food Science Technology Abstracts genetically modified microorganism multi locus sequence analysis EFSA Panel on Dietetic Products, Nutrition and Allergies Qualified Presumption of Safety resistance‐nodulation‐division Term of Reference Arthrobacter ramosus A literature search was performed in Web of Science Core collection, using the search terms “Arthrobacter ramosus”, considering all years available: a total of 15 hits, plus the Bergey's Manual of Systematic Bacteriology, section “Arthrobacter”, were identified and screened. Pseudomonas fluorescens A literature search was performed in Web of Science Core collection, considering all years available: using the search terms “Pseudomonas fluorescens phylogeny” a total of 52 hits were identified and screened; “Pseudomonas fluorescens” AND “antibiotic resistance” AND “mechanisms” a total of 85 hits were identified and screened; and “Pseudomonas fluorescens” AND “safety” AND (“infection”, OR “hospitalisation” OR “outbreak” OR “disease” OR “immunocompromised” OR “Crohn‘s disease” OR “opportunist”) a total of 20 hits were identified and screened. Bacillus smithii A literature search was performed in Web of Science Core collection using the search terms “Bacillus smithii”, considering all years available: a total of 48 hits were identified and screened. The previous list of QPS status recommended biological agents for safety risk assessments carried out by EFSA Scientific Panels and Units, as shown in Table B.1 below, was revised in accordance with a self‐task mandate of the BIOHAZ Panel. The previous QPS list (EFSA BIOHAZ Panel, 2013) has been revised so as to include new additions and has been published as an Appendix to the Statements of the BIOHAZ Panel published around every 6 months until July 2016. This is the most up‐to‐date QPS list, including also the new additions, and is also published on the web as a separate file.
Table B.1

The 2016 updated list of QPS status recommended biological agents for safety risk assessments carried out by EFSA Scientific Panels and Units

Bacteria
Gram‐positive non‐sporulating bacteria
Species Qualifications a

Bifidobacterium adolescentis

Bifidobacterium animalis

Bifidobacterium bifidum

Bifidobacterium breve

Bifidobacterium longum
Carnobacterium divergens b
Corynebacterium glutamicum c QPS only applies when the species is used for amino acid production.

Lactobacillus acidophilus

Lactobacillus amylolyticus

Lactobacillus amylovorus

Lactobacillus alimentarius

Lactobacillus aviaries

Lactobacillus brevis

Lactobacillus buchneri

Lactobacillus casei d

Lactobacillus cellobiosus

Lactobacillus collinoides

Lactobacillus coryniformis

Lactobacillus crispatus

Lactobacillus curvatus

Lactobacillus delbrueckii

Lactobacillus diolivorans e

Lactobacillus farciminis

Lactobacillus fermentum

Lactobacillus gallinarum

Lactobacillus gasseri

Lactobacillus helveticus

Lactobacillus hilgardii

Lactobacillus johnsonii

Lactobacillus kefiranofaciens

Lactobacillus kefiri

Lactobacillus mucosae

Lactobacillus panis

Lactobacillus paracasei

Lactobacillus paraplantarum

Lactobacillus pentosus

Lactobacillus plantarum

Lactobacillus pontis

Lactobacillus reuteri

Lactobacillus rhamnosus

Lactobacillus sakei

Lactobacillus salivarius

Lactobacillus sanfranciscensis

Lactococcus lactis

Leuconostoc citreum

Leuconostoc lactis

Leuconostoc mesenteroides Leuconostoc pseudomesenteroides
Microbacterium imperiale b QPS only applies when the species is used for enzyme production.
Oenococcus oeni
Pasteuria nishizawae f

Pediococcus acidilactici

Pediococcus dextrinicus

Pediococcus parvulus e Pediococcus pentosaceus
Propionibacterium freudenreichii Propionibacterium acidipropionici
Streptococcus thermophilus
Gram‐positive spore‐forming bacteria
Bacillus
Species Qualifications a

Bacillus amyloliquefaciens

Bacillus atrophaeus

Bacillus clausii

Bacillus coagulans

Bacillus flexus e

Bacillus fusiformis

Bacillus lentus

Bacillus licheniformis

Bacillus megaterium

Bacillus mojavensis

Bacillus pumilus

Bacillus smithii g

Bacillus subtilis

Bacillus vallismortis

Absence of toxigenic activity.
Gram‐positive spore‐forming bacteria
Species Qualifications a
Geobacillus stearothermophilus Absence of toxigenic activity.
Gram‐negative bacteria
Species Qualifications a
Gluconobacter oxydans QPS only applies when the species is used for vitamin production.
Xanthomonas campestris h QPS only applies when the species is used for the production of xanthan gum.
Yeasts i
Species Qualifications
Candida cylindracea b QPS only applies when the species is used for enzyme production.
Debaryomyces hansenii
Hanseniaspora uvarum
Kluyveromyces lactis Kluyveromyces marxianus

Komagataella pastoris

Lindnera jadinii

Ogataea angusta

QPS only applies when the species is used for enzyme production.
Saccharomyces bayanus Saccharomyces cerevisiae j Saccharomyces pastorianus

Absence of resistance to antimycotics used for medical treatment of yeast infections in cases where viable cells are added to the food or feed chain

Saccharomyces cerevisiae this qualification applies for yeast strains able to grow above 37°C.

Schizosaccharomyces pombe
Wickerhamomyces anomalus

QPS only applies when the species is used for enzyme production.

Absence of resistance to antimycotics used for medical treatment of yeast infections in cases where viable cells are added to the food or feed chain.

Xanthophyllomyces dendrorhous
Viruses
Plant viruses
Family
AlphaflexiviridaePotyviridae
Insect viruses
Family
Baculoviridae

A specific representative of a QPS proposed taxonomic unit, does not need to undergo a further safety assessment other than to satisfy the specified qualifications, if applicable. On the other hand, representatives of taxonomic units that fail to satisfy a qualification would be considered unfit for the QPS list and would remain subject to a full safety assessment, in the frame of a notification by the responsible EFSA Scientific Panel.

Generic qualification for all QPS bacterial taxonomic units: the strains should not harbour any acquired antimicrobial resistance genes to clinically relevant antimicrobials.

Microorganisms recommended in the Panel Statement published in December 2014.

Brevibacterium lactofermentum is a synonym of Corynebacterium glutamicum.

The previously described species ‘Lactobacillus zeae’ has been included in the species Lactobacillus casei.

Microorganisms recommended in the Panel Statement published in June 2016.

Microorganisms recommended in the Panel Statement published in December 2015.

Microorganisms recommended in this Panel Statement published in January 2017.

Microorganisms recommended in the Panel Statement published in June 2015.

Yeast synonyms commonly used in the feed/food industry:

Debaryomyces hansenii: anamorph Candida famata;

Hanseniaspora uvarum: anamorph Kloeckera apiculata;

Kluyveromyces lactis: anamorph Candida spherica;

Kluyveromyces marxianus: anamorph Candida kefyr;

Komagataella pastoris: synonym Pichia pastoris;

Lindnera jadinii: synonyms Pichia jadinii, Hansenula jadinii, Torulopsis utilis, anamorph Candida utilis;

Ogataea angusta: synonym Pichia angusta;

Saccharomyces cerevisiae: synonym Saccharomyces boulardii;

Saccharomyces pastorianus: synonym Saccharomyces carlsbergensis;

Wickerhamomyces anomalus: synonyms Hansenula anomala, Pichia anomala, Saccharomyces anomalus, anamorph Candida pelliculosa;

Xanthophyllomyces dendrorhous: anamorph Phaffia rhodozyma.

Saccharomyces cerevisiae, subtype boulardii is contraindicated for persons with fragile health, as well as for patients with a central venous catheter in place.

The 2016 updated list of QPS status recommended biological agents for safety risk assessments carried out by EFSA Scientific Panels and Units Bifidobacterium adolescentis Bifidobacterium animalis Bifidobacterium bifidum Bifidobacterium breve Lactobacillus acidophilus Lactobacillus amylolyticus Lactobacillus amylovorus Lactobacillus alimentarius Lactobacillus aviaries Lactobacillus brevis Lactobacillus buchneri Lactobacillus casei d Lactobacillus cellobiosus Lactobacillus collinoides Lactobacillus coryniformis Lactobacillus crispatus Lactobacillus curvatus Lactobacillus delbrueckii Lactobacillus diolivorans e Lactobacillus farciminis Lactobacillus fermentum Lactobacillus gallinarum Lactobacillus gasseri Lactobacillus helveticus Lactobacillus hilgardii Lactobacillus johnsonii Lactobacillus kefiranofaciens Lactobacillus kefiri Lactobacillus mucosae Lactobacillus panis Lactobacillus paracasei Lactobacillus paraplantarum Lactobacillus pentosus Lactobacillus plantarum Lactobacillus pontis Lactobacillus reuteri Lactobacillus rhamnosus Lactobacillus sakei Lactobacillus salivarius Lactobacillus sanfranciscensis Leuconostoc citreum Leuconostoc lactis Pediococcus acidilactici Pediococcus dextrinicus Bacillus amyloliquefaciens Bacillus atrophaeus Bacillus clausii Bacillus coagulans Bacillus flexus e Bacillus fusiformis Bacillus lentus Bacillus licheniformis Bacillus megaterium Bacillus mojavensis Bacillus pumilus Bacillus smithii g Bacillus subtilis Bacillus vallismortis Komagataella pastoris Lindnera jadinii Ogataea angusta Absence of resistance to antimycotics used for medical treatment of yeast infections in cases where viable cells are added to the food or feed chain Saccharomyces cerevisiae this qualification applies for yeast strains able to grow above 37°C. QPS only applies when the species is used for enzyme production. Absence of resistance to antimycotics used for medical treatment of yeast infections in cases where viable cells are added to the food or feed chain. A specific representative of a QPS proposed taxonomic unit, does not need to undergo a further safety assessment other than to satisfy the specified qualifications, if applicable. On the other hand, representatives of taxonomic units that fail to satisfy a qualification would be considered unfit for the QPS list and would remain subject to a full safety assessment, in the frame of a notification by the responsible EFSA Scientific Panel. Generic qualification for all QPS bacterial taxonomic units: the strains should not harbour any acquired antimicrobial resistance genes to clinically relevant antimicrobials. Microorganisms recommended in the Panel Statement published in December 2014. Brevibacterium lactofermentum is a synonym of Corynebacterium glutamicum. The previously described species ‘Lactobacillus zeae’ has been included in the species Lactobacillus casei. Microorganisms recommended in the Panel Statement published in June 2016. Microorganisms recommended in the Panel Statement published in December 2015. Microorganisms recommended in this Panel Statement published in January 2017. Microorganisms recommended in the Panel Statement published in June 2015. Yeast synonyms commonly used in the feed/food industry: Debaryomyces hansenii: anamorph Candida famata; Hanseniaspora uvarum: anamorph Kloeckera apiculata; Kluyveromyces lactis: anamorph Candida spherica; Kluyveromyces marxianus: anamorph Candida kefyr; Komagataella pastoris: synonym Pichia pastoris; Lindnera jadinii: synonyms Pichia jadinii, Hansenula jadinii, Torulopsis utilis, anamorph Candida utilis; Ogataea angusta: synonym Pichia angusta; Saccharomyces cerevisiae: synonym Saccharomyces boulardii; Saccharomyces pastorianus: synonym Saccharomyces carlsbergensis; Wickerhamomyces anomalus: synonyms Hansenula anomala, Pichia anomala, Saccharomyces anomalus, anamorph Candida pelliculosa; Xanthophyllomyces dendrorhous: anamorph Phaffia rhodozyma. Saccharomyces cerevisiae, subtype boulardii is contraindicated for persons with fragile health, as well as for patients with a central venous catheter in place. To be evaluated? Yes or nob CEF: EFSA Panel on Food Contact Materials, Enzymes, Flavourings and Processing Aids; FEEDAP: EFSA Panel on Additives and products or Substances used in Animal Feed; FIP: EFSA Food ingredients and packaging Unit; GMM: genetically modified microorganism; NDA: EFSA Panel on Dietetic Products, Nutrition and Allergy; QPS: Qualified Presumption of Safety. Not present in the QPS list as published in the 2013 QPS update scientific opinion (version before the publication of this Panel statement). In the current statement. The 2016 updated list of QPS status recommended biological agents in support of EFSA risk assessments Click here for additional data file.
EFSA Unit/PanelMicroorganism species/strainIntended use EFSA register of questions and EFSA Journal Additional information provided by the EFSA Scientific UnitPrevious QPS status?a

To be evaluated?

Yes or nob

Bacteria
FIP/CEP Arthrobacter ramosus Production of food enzymeEFSA‐Q‐2016‐00135The food enzyme is a 4‐alpha‐d‐{(1→4)a‐d‐glucano} trehalose trehalohydrolaseNoYes
FIP/CEP Arthrobacter ramosus Production of food enzymeEFSA‐Q‐2016‐00136The food enzyme is a (1→4)‐alpha‐d‐glucan 1‐alpha‐d‐glucosylmutaseNoYes
FIP/CEP Bacillus amyloliquefaciens Production of food enzymeEFSA‐Q‐2015‐00846The food enzyme is an alpha‐amylaseYesNo
FIP/CEP Bacillus circulans (strain M3‐1)Production of food enzymeEFSA‐Q‐2016‐00210The food enzyme is a beta‐galactosidaseNoNo
Feed/FEEDAP Bacillus coagulans Production of lactic acidEFSA‐Q‐2016‐00645YesNo
FIP/CEP Bacillus licheniformis (DP‐Dzb44)Production of food enzymeEFSA‐Q‐2015‐00836The food enzyme is an alpha‐amylase by a GMM strainYesNo
FIP/CEP Bacillus licheniformis/DP‐Dzr46Production of food enzymeEFSA‐Q‐2016‐00095The food enzyme is a glucan 1,4‐alpha‐maltohydrolase produced by a GMM strainYesNo
FIP/CEP Bacillus licheniformis/DP‐Dzr50Production of food enzymeEFSA‐Q‐2016‐00096The food enzyme is a glucan 1,4‐alpha‐maltohydrolase produced by a GMM strainYesNo
FIP/CEP Bacillus licheniformis/DP‐Dzr52Production of food enzymeEFSA‐Q‐2016‐00093The food enzyme is an alpha‐amylase produced by a GMM strainYesNo
Feed/FEEDAPBacillus smithiiProduction of lactic acidEFSA‐Q‐2016‐00645NoYes
Feed/FEEDAP Bacillus subtilis Production of lactic acidEFSA‐Q‐2016‐00645YesNo
FIP/CEP Bacillus subtilis Production of food enzymeEFSA‐Q‐2016‐00133The food enzyme is an alpha‐amylaseYesNo
FIP/CEP Bacillus subtilis (strain 11096)Production of food enzymeEFSA‐Q‐2016‐00207The food enzyme is a pectate lyaseYesNo
Feed/FEEDAP Bacillus subtilis CJKB0001Production of vitamin B2EFSA‐Q‐2016‐00505YesNo
FIP/CEP Bacillus subtilis (DP‐Ezd31)Production of food enzymeEFSA‐Q‐2015‐00839The food enzyme is an endo‐1,4‐beta‐xylanase by a GMM strainYesNo
FIP/CEP Bacillus subtilis (DP‐Ezg29)Production of food enzymeEFSA‐Q‐2015‐00838The food enzyme is a beta‐galactosidase by a GMM strainYesNo
FIP/CEP Bacillus subtilis (DP‐Ezm28)Production of food enzymeEFSA‐Q‐2015‐00828The food enzyme is an endo‐1,3(4)‐beta‐glucanase by a GMM strainYesNo
Feed/FEEDAP Bacillus subtilis DSM 29784Zootechnical additiveEFSA‐Q‐2016‐00448YesNo
Pesticides Bacillus subtilis strain QST 713Plant protection productEFSA‐Q‐2016‐00172Application for renewal of approval (AIR III)YesNo
Feed/FEEDAP Corynebacterium glutamicum Production of lysineEFSA‐Q‐2016‐00574YesNo
Feed/FEEDAP Corynebacterium glutamicum KCCM80099Production of l‐arginineEFSA‐Q‐2016‐00405YesNo
Feed/FEEDAP Enterococcus faecium DSM 7134Zootechnical additiveEFSA‐Q‐2016‐00450NoNo
Feed/FEEDAP Enterococcus faecium DSM 7134Zootechnical additiveEFSA‐Q‐2016‐00452NoNo
Feed/FEEDAP Escherichia coli CGMCC 3667Production of tryptophane EFSA‐Q‐2016‐00551 NoNo
Feed/FEEDAP Escherichia coli (ATCC 9637)Production of histidineEFSA‐Q‐2016‐00304NoNo
Feed/FEEDAP Escherichia coli (ATCC 9637)Production of histidineEFSA‐Q‐2016‐00305NoNo
FIP/CEP Escherichia coli (BglA MCB3)Production of food enzymeEFSA‐Q‐2015‐00622The food enzyme is a beta‐galactosidase by a GMM strainNoNo
Feed/FEEDAP Lactobacillus farciminis CNMA67/4RZootechnical additiveEFSA‐Q‐2016‐00712YesNo
NDA/Nutrition Lactobacillus fermentum CECT5716Food targeted for health claimsEFSA‐Q‐2016‐00318 In the framework of the EU Regulation 1924/2006 on health claims made on foods, EFSA is only requested to perform efficay assessment (i.e. relationship between the food consumption and the claimed beneficial effect). Safety assessment is not foreseen.YesNo
Feed/FEEDAP Lactobacillus hilgardii CNMC I‐4785Technological additiveEFSA‐Q‐2016‐00580YesNo
NDA/Nutrition“Nutrimune (a heat‐treated fermented milk, fermented with Lactobacillus paracasei CBA L74)”Food targeted for health claims EFSA-Q-2015-00755 In the framework of the EU Regulation 1924/2006 on health claims made on foods, EFSA is only requested to perform efficay assessment (i.e. relationship between the food consumption and the claimed beneficial effect). Safety assessment is not foreseen.YesNo
NDA/Nutrition Lactobacillus plantarum 299vFood targeted for health claims: “increase of non‐haem iron absorption”EFSA‐Q‐2015‐00696In the framework of the EU Regulation 1924/2006 on health claims made on foods, EFSA is only requested to perform efficay assessment (i.e. relationship between the food consumption and the claimed beneficial effect). Safety assessment is not foreseen.YesNo
NDA/Nutrition Lactobacillus rhamnosus GG (ATCC 53103) and fructooligosaccharides (FOS)Food targeted for health claims: “helps to reduce recurrence of lip cold sores caused by Herpes simplex virus infection in healthy susceptible individuals” EFSA-Q-2015-00488 In the framework of the EU Regulation 1924/2006 on health claims made on foods, EFSA is only requested to perform efficay assessment (i.e. relationship between the food consumption and the claimed beneficial effect). Safety assessment is not foreseen.YesNo
FIP/CEP Lactococcus lactis (strain DGCC5920)Production of food enzymeEFSA‐Q‐2016‐00208The food enzyme is a membrane alanyl aminopeptidaseYesNo
Feed/FEEDAP Lactococcus lactis NCIMB 30160Technological additiveEFSA‐Q‐2016‐00568YesNo
FIP/CEP Leuconostoc citreum (strain NRRL B‐30894)Production of food enzymeEFSA‐Q‐2016‐00209The food enzyme is an alternansucraseYesNo
FIP/CEP Pseudomonas fluorescens (BD15754)Production of food enzymeEFSA‐Q‐2016‐00200The food enzyme is an alpha‐amylase by a GMM strainNoYes
Feed/FEEDAP Streptomyces albus Production of coccidostatFAD‐2016‐0044NoNo
FIP/CEP Streptomyces violaceoruber (strain AS‐10)Production of food enzymeEFSA‐Q‐2016‐00132The food enzymes is a phospholipase A2 by a GMM strainNoNo
FIP/CEP Streptomyces violaceoruber (pChi)Production of food enzymeEFSA‐Q‐2015‐00621The food enzyme is a chitinase by a GMM strainNoNo
FIP/CEP Streptomyces violaceoruber (strain pCol)Production of food enzymeEFSA‐Q‐2015‐00826The food enzyme is a microbial collagenase by a GMM strainNoNo
Filamentous fungi
Feed/FEEDAP Aspergillus niger CBS 109.713Production of feed enzyme EFSA-Q-2016-00302 The feed enzyme is endo‐1,4‐beta‐xylanase and endo‐1,4‐beta‐glucanaseNoNo
FIP/CEP Aspergillus oryzae (strain L729‐48)Production of food enzymeEFSA‐Q‐2016‐00205The food enzyme is an alpha‐amylaseNoNo
FIP/CEP Aspergillus oryzae (strains NBRC 110971 and 11‐5)Production of food enzymeEFSA‐Q‐2016‐00272The food enzyme is a tannaseNoNo
FIP/CEP Aspergillus niger (strain NZYM‐KA)Production of food enzymeEFSA‐Q‐2016‐00134The food enzyme is a glucose oxidaseNoNo
FIP/CEP Penicillium funiculosum (DP‐Lzc35)Production of food enzymeEFSA‐Q‐2016‐00098The food enzyme is a cellulaseNoNo
FIP/CEP Rhizomucor miehei (strain 29547)Production of food enzymeEFSA‐Q‐2015‐00761The food enzyme is a mucorpepsinNoNo
FIP/CEP Trichoderma reesei/DP‐Dzh34Production of food enzymeEFSA‐Q‐2016‐00097The food enzyme is a glucan 1,4‐alpha‐glucosidase produced by a GMM strainNoNo
FIP/CEP Trichoderma reesei/DP‐Nzh49Production of food enzymeEFSA‐Q‐2016‐00094The food enzyme is a glucan 1,4‐alpha‐glucosidase produced by a GMM strainNoNo
Yeasts
Feed/FEEDAP Pichia pastoris (DSM 23036)Production of feed enzymeEFSA‐Q‐2016‐00291The feed anzyme is 6‐phytaseYesNo
FIP/CEP Pichia pastoris (PRF)Production of food enzymeEFSA‐Q‐2016‐00201The food enzyme is a phospholipase C by a GMM strainYesNo
Feed/FEEDAP Saccharomyces cerevisiae Zootechnical additiveEFSA‐Q‐2016‐00292YesNo
Feed/FEEDAP Saccharomyces cerevisiae Zootechnical additiveEFSA‐Q‐2016‐00297YesNo
Feed/FEEDAP Saccharomyces cerevisiae Zootechnical additiveEFSA‐Q‐2016‐00298YesNo
Feed/FEEDAP Saccharomyces cerevisiae CNCM I‐1079Zootechnical additiveEFSA‐Q‐2016‐00449YesNo
Feed/FEEDAP Saccharomyces cerevisiae CNCM I‐3399Production of histidineEFSA‐Q‐2016‐00346YesNo
Feed/FEEDAP Schizosaccharomyces pombe Production of phytaseEFSA‐Q‐2016‐00559YesNo

CEF: EFSA Panel on Food Contact Materials, Enzymes, Flavourings and Processing Aids; FEEDAP: EFSA Panel on Additives and products or Substances used in Animal Feed; FIP: EFSA Food ingredients and packaging Unit; GMM: genetically modified microorganism; NDA: EFSA Panel on Dietetic Products, Nutrition and Allergy; QPS: Qualified Presumption of Safety.

Not present in the QPS list as published in the 2013 QPS update scientific opinion (version before the publication of this Panel statement).

In the current statement.

  10 in total

Review 1.  Therapeutic Anti-Depressant Potential of Microbial GABA Produced by Lactobacillus rhamnosus Strains for GABAergic Signaling Restoration and Inhibition of Addiction-Induced HPA Axis Hyperactivity.

Authors:  Fernanda-Marie Tette; Samuel K Kwofie; Michael D Wilson
Journal:  Curr Issues Mol Biol       Date:  2022-03-22       Impact factor: 2.976

2.  Effect of Lactic Acid Bacteria Strains on the Growth and Aflatoxin Production Potential of Aspergillus parasiticus, and Their Ability to Bind Aflatoxin B1, Ochratoxin A, and Zearalenone in vitro.

Authors:  Cleide Oliveira de Almeida Møller; Luisa Freire; Roice Eliana Rosim; Larissa Pereira Margalho; Celso Fasura Balthazar; Larissa Tuanny Franco; Anderson de Souza Sant'Ana; Carlos Humberto Corassin; Fergal Patrick Rattray; Carlos Augusto Fernandes de Oliveira
Journal:  Front Microbiol       Date:  2021-04-22       Impact factor: 5.640

3.  Safety evaluation of the food enzyme alternansucrase from Leuconostoc citreum strain NRRL B-30894.

Authors:  Vittorio Silano; José Manuel Barat Baviera; Claudia Bolognesi; Pier Sandro Cocconcelli; Riccardo Crebelli; David Michael Gott; Konrad Grob; Claude Lambré; Evgenia Lampi; Marcel Mengelers; Alicja Mortensen; Gilles Rivière; Inger-Lise Steffensen; Christina Tlustos; Henk Van Loveren; Laurence Vernis; Holger Zorn; Boet Glandorf; Lieve Herman; André Penninks; Jaime Aguilera; Margarita Aguilera-Gomez; Magdalena Andryszkiewicz; Natália Kovalkovičová; Yi Liu; Claudia Roncancio Peña; Andrew Chesson
Journal:  EFSA J       Date:  2021-01-19

4.  Enhancement of the antibacterial potential of plantaricin by incorporation into silver nanoparticles.

Authors:  Sara Adel Amer; Hala Mohamed Abushady; Rasha Mohamed Refay; Mahmoud Ahmed Mailam
Journal:  J Genet Eng Biotechnol       Date:  2021-01-20

5.  A Rapid Screening Method of Candidate Probiotics for Inflammatory Bowel Diseases and the Anti-inflammatory Effect of the Selected Strain Bacillus smithii XY1.

Authors:  Xuedi Huang; Fang Ai; Chen Ji; Pengcheng Tu; Yufang Gao; Yalan Wu; Fujie Yan; Ting Yu
Journal:  Front Microbiol       Date:  2021-12-17       Impact factor: 5.640

6.  Efficacy and Safety of Lactobacillus plantarum K50 on Lipids in Koreans With Obesity: A Randomized, Double-Blind Controlled Clinical Trial.

Authors:  Minji Sohn; Ga Yoon Na; Jaeryang Chu; Hyunchae Joung; Byung-Kook Kim; Soo Lim
Journal:  Front Endocrinol (Lausanne)       Date:  2022-01-19       Impact factor: 5.555

7.  Formulation and Safety Tests of a Wickerhamomyces anomalus-Based Product: Potential Use of Killer Toxins of a Mosquito Symbiotic Yeast to Limit Malaria Transmission.

Authors:  Alessia Cappelli; Consuelo Amantini; Federica Maggi; Guido Favia; Irene Ricci
Journal:  Toxins (Basel)       Date:  2021-09-23       Impact factor: 4.546

Review 8.  The Impacts of Lactiplantibacillus plantarum on the Functional Properties of Fermented Foods: A Review of Current Knowledge.

Authors:  Birsen Yilmaz; Sneh Punia Bangar; Noemi Echegaray; Shweta Suri; Igor Tomasevic; Jose Manuel Lorenzo; Ebru Melekoglu; João Miguel Rocha; Fatih Ozogul
Journal:  Microorganisms       Date:  2022-04-15

9.  Safety Evaluation of Yeasts With Probiotic Potential.

Authors:  Pilar Fernández-Pacheco; Inés María Ramos Monge; Mónica Fernández-González; Justa María Poveda Colado; María Arévalo-Villena
Journal:  Front Nutr       Date:  2021-05-21

Review 10.  Probiotics: Should All Patients Take Them?

Authors:  Marta Katkowska; Katarzyna Garbacz; Aida Kusiak
Journal:  Microorganisms       Date:  2021-12-18
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.